Co-Arinate FDC Tablets - 3 Count

Product Overview

Co-Arinate FDC is a fixed-dose combination antimalarial medication used for the effective treatment of acute uncomplicated malaria, especially caused by Plasmodium falciparum. Each tablet contains a synergistic combination of Artesunate and Amodiaquine, delivering a potent, fast-acting, and reliable solution against malaria.

This 3-tablet pack is designed to complete a standard course over 3 days, making it ideal for patient compliance, rapid symptom relief, and parasite clearance.

Key Features

• Active Ingredients: Artesunate and Amodiaquine (fixed-dose combination)
• Formulation: Oral tablets
• Pack Size: 3 tablets (1 tablet per day for 3 days)
• Primary Actions:
  • Rapid clearance of malaria parasites from the bloodstream
  • Effective treatment of uncomplicated falciparum malaria
  • Reduces transmission and likelihood of recurrence
• Dosage: 1 tablet once daily for 3 consecutive days, or as directed by a healthcare provider

Indications

• Treatment of acute uncomplicated malaria caused by P. falciparum
• Effective in areas with documented resistance to older antimalarials

Benefits

• Fast-acting and well-tolerated
• Convenient once-daily dosing for 3 days
• Reduces fever and parasite count quickly
• Effective even in chloroquine-resistant regions

Precautions and Warnings

• Use only under medical supervision, especially in children or pregnant women.
• Not recommended for individuals with known hypersensitivity to artemisinin or amodiaquine derivatives.
• May cause mild side effects such as nausea, dizziness, or fatigue.
• Inform your healthcare provider of any liver problems or other medications being taken.